With a torrent of venture cash gushing from a global pack of unicorn hunters, this biotech founder vows to stay hungry
Whatever factors may be limiting the ambitions of Tessera, ready cash isn’t one of them.
The startup that debuted in a pandemic, inspired by a new approach to gene editing — perhaps the hottest of all sizzling new biotech trends — and focused on building the next big platform play, has organized a unicorn-hunting global syndicate of backers to fund a hiring spree as they set a course to the clinic.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.